Alignment Healthcare (ALHC) Stock Price, News & Analysis

Company Overview

Alignment Healthcare, Inc. is a technology-enabled healthcare company that provides Medicare Advantage health plans and care-management services for older adults. Through its Alignment Health Plan subsidiary, the company offers insurance coverage designed for Medicare-eligible members, including primary and specialty care coordination, prescription drug benefits, preventive services and access to a network of healthcare providers.

The company combines health-plan operations with proprietary technology intended to support personalized care. Its services may include virtual care, in-home clinical support, care navigation and assistance for members managing chronic conditions. Alignment also uses data and analytics to help coordinate care, identify members who may need additional support and improve communication among patients, physicians and health-plan teams.

Alignment Healthcare serves Medicare Advantage members in selected markets across the United States, with operations concentrated in states including California and other regional markets. The company was founded in 2013 and became a publicly traded company in 2021. Alignment was co-founded by John Kao, who serves as chief executive officer.

Key Stats

• Today's Range: $8.31 to $8.78
• 50-Day Range: $8.35 to $21.50
• 52-Week Range: $8.27 to $25.12
• Volume: 23.59 million shs
• Average Volume: 7.41 million shs
• Market Capitalization: $1.73 billion
• P/E Ratio: 43.95
• Dividend Yield: N/A
• Price Target: $23.60
• Consensus Rating: Moderate Buy

Alignment Healthcare Stock Analysis - MarketRank™

Alignment Healthcare scored higher than 85% of companies evaluated by MarketBeat, and ranked 63rd out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Alignment Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.64, and is based on no strong buy ratings, 7 buy ratings, 4 hold ratings, and no sell ratings.

Upside Potential

Alignment Healthcare has a consensus price target of $23.60, representing about 182.6% upside from its current price of $8.35.

Amount of Analyst Coverage

Alignment Healthcare has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 147.06%

Earnings Growth

Earnings for Alignment Healthcare are expected to grow by 147.06% in the coming year, from $0.17 to $0.42 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Alignment Healthcare is 43.95, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.95.

Price to Earnings Ratio vs. Sector

The P/E ratio of Alignment Healthcare is 43.95, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.79.

Price to Book Value per Share Ratio

Alignment Healthcare has a P/B Ratio of 9.28. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

11.61% of the float of Alignment Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Alignment Healthcare has a short interest ratio ("days to cover") of 6.04.

Change versus previous month

Short interest in Alignment Healthcare has recently decreased by 2.96%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Alignment Healthcare does not currently pay a dividend.

Dividend Growth

Alignment Healthcare does not have a long track record of dividend growth.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.31

News Sentiment

Alignment Healthcare has a news sentiment score of 0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 32 news articles for Alignment Healthcare this week, compared to 9 articles on an average week.

Search Interest

Only 15 people have searched for ALHC on MarketBeat in the last 30 days. This is a decrease of -6% compared to the previous 30 days.

MarketBeat Follows

6 people have added Alignment Healthcare to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.6 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Alignment Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $20,466,194.00 in company stock.

Percentage Held by Insiders

5.20% of the stock of Alignment Healthcare is held by insiders.

Percentage Held by Institutions

86.19% of the stock of Alignment Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/30/2026
• Today: 9/19/2026
• Next Earnings (Estimated): 10/29/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Managed Healthcare
• Current Symbol: NASDAQ:ALHC
• CIK: 1832466
• Web: www.alignmenthealth.com
• Phone: 844-310-2247
• Fax: N/A
• Employees: 1,849
• Year Founded: 2013

Price Target and Rating

• Average Price Target for Alignment Healthcare: $23.60
• High Price Target: $30.00
• Low Price Target: $16.00
• Potential Upside/Downside: +182.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.64
• Research Coverage: 11 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.19
• Trailing P/E Ratio: 43.95
• Forward P/E Ratio: 49.12
• P/E Growth: N/A
• Net Income: -$720 thousand
• Net Margins: 0.89%
• Pretax Margin: 0.85%
• Return on Equity: 20.02%
• Return on Assets: 3.46%

Debt

• Debt-to-Equity Ratio: 1.22
• Current Ratio: 1.70
• Quick Ratio: 1.70

Sales & Book Value

• Annual Sales: $3.95 billion
• Price / Sales: 0.44
• Cash Flow: $0.14 per share
• Price / Cash Flow: 57.60
• Book Value: $0.90 per share
• Price / Book: 9.28

Miscellaneous

• Outstanding Shares: 207,430,000
• Free Float: 196,648,000
• Market Cap: $1.73 billion
• Optionable: Optionable
• Beta: 1.11